UK Protects Queers from the Ripper
- LONDON – Gonorrhea cases in the United Kingdom have surged to levels not seen in over a century, prompting health officials to launch a targeted vaccination program.
- The National health Service (NHS) is focusing its new vaccination program on individuals deemed at "especially high risk," specifically gay and bisexual men with a recent history of...
- "This vaccination program is a game-changer for queer health," said Richard Angell, Managing Director of the Terrence Higgins Trust, a leading British sexual health association.
UK Faces Gonorrhea Surge; New Vaccination Program Targets High-Risk Groups
LONDON – Gonorrhea cases in the United Kingdom have surged to levels not seen in over a century, prompting health officials to launch a targeted vaccination program. The UK Health Security Agency (UKHSA) reported over 85,000 cases in 2023, a figure matching those recorded in 1918. Of particular concern is the increasing prevalence of antibiotic-resistant strains, rendering traditional treatments less effective.
Gay and Bisexual Men Targeted in Vaccination Effort
The National health Service (NHS) is focusing its new vaccination program on individuals deemed at “especially high risk,” specifically gay and bisexual men with a recent history of multiple sexual partners or bacterial sexually transmitted infections. This strategy reflects the disproportionate impact of gonorrhea on this demographic. Public Health England data indicates that over half of gonorrhea diagnoses prior to the pandemic were among men who have sex with men (MSM), despite this group representing a smaller percentage of the overall population.
“This vaccination program is a game-changer for queer health,” said Richard Angell, Managing Director of the Terrence Higgins Trust, a leading British sexual health association. “this measure alone could prevent up to 40 percent of new infections.”
Richard angell, Managing Director, Terrence Higgins Trust
Existing vaccine, Novel application
The vaccine being deployed, 4CMenB, is currently part of the UK’s standard childhood immunization schedule, protecting against meningococcal B infections. Studies have demonstrated that this vaccine can also provide partial cross-protection against gonorrhea. This marks the first time the vaccine is being administered to adults, a pioneering move in global vaccination policy.
In addition to gonorrhea protection, participants in the program will also receive vaccinations against HPV, hepatitis A and B, and mpox (formerly monkeypox) – diseases that have disproportionately affected the LGBTQ+ community.
Syphilis Also on the Rise
The rise in gonorrhea cases coincides with a resurgence of other sexually transmitted infections. Syphilis, once considered a disease of the past, is also experiencing a resurgence. The UKHSA reported 9,513 syphilis cases in 2023, a more than nine percent increase compared to the previous year and the highest figure since 1948.
“We see worrying developments that urgently require new strategies,” said Sema Mandal, senior epidemiologist at the UKHSA.Many experts believe that shifting the focus to vaccination, rather than solely relying on treatment, is a necessary step.
